If you have a transgender child in New York, access to gender-affirming care just got easier. The state attorney general stepped in to order NYU Langone Health to resume puberty blockers and hormone therapies, reversing a halt triggered by federal funding threats and allowing scheduled treatments to resume.
The Attorney General's Directive
The New York attorney general issued a clear order compelling NYU Langone Health to immediately restore gender-affirming care for adolescents. This action followed the hospital's decision to pause treatments, which stemmed from warnings by federal officials about potential loss of funding. For families who had appointments canceled, this means doctors can now proceed with medications that help manage gender dysphoria.
What Led to the Hospital's Pause
NYU Langone Health stopped providing puberty-blocking drugs and hormone treatments after the federal government signaled it might cut financial support. Hospital leaders cited compliance with federal regulations as their reason, fearing the impact on broader operations. This pause left young patients without access to care that medical guidelines recognize as important for mental health.
A Tale of Two States
In Texas, Attorney General Ken Paxton took a contrasting stance by declaring it illegal for mental health providers to offer gender transition services to minors. His opinion is based on Texas S.B. 14, a 2023 state law that prohibits puberty blockers, hormone therapy, and related treatments for adolescents. New York and Texas have adopted contrasting policies. Supporters of the Texas restrictions argue they protect minors from premature medical decisions; opponents contend they deny necessary care.
How This Changes Lives
The New York attorney general's order requires NYU Langone Health to resume providing puberty-blocking medication and hormone treatments for transgender youth. Medical organizations including the American Academy of Pediatrics support puberty blockers for gender dysphoria, though some medical professionals dispute their safety and appropriateness for minors. In Texas, the restrictions prevent access to these treatments within the state. Families seeking care may need to travel out of state.
New York and Texas have adopted contrasting policies on gender-affirming care for minors. The New York attorney general ordered hospitals to resume these treatments. Texas law prohibits them. These divergent approaches reflect ongoing disagreement among policymakers, medical professionals, and families about the appropriate role of these treatments in adolescent care.
